Skip to content
healthcare.dev

RIVAROXABAN

NDC 68180-709, RIVAROXABAN, tablet, film coated, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-709
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
68180-709-066818007090630 TABLET, FILM COATED in 1 BOTTLE (68180-709-06)
68180-709-096818007090990 TABLET, FILM COATED in 1 BOTTLE (68180-709-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/702fed3e-ae25-49ba-98cc-562e0e244214
  • NADAC price for package 68180070906

    GET /v1/drugs/nadac/68180070906
  • NADAC price for package 68180070909

    GET /v1/drugs/nadac/68180070909

Use it

Look up 68180-709 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-709 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-709. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.